Atlas Trials

Bioequivalence Study of Capsule and Tablet Formulations of TA-8995

Clinical trial NCT02523391 · COMPLETED

Trial details

NCT number
NCT02523391
Sponsor
Xention Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidaemia
Start date
2015-07-01
Primary completion
2015-11-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.